Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 1/2
×
patritumab deruxtecan
×
Thoracic
×
Clear all
Filters
3
NCT04165070
2026-03-16
MK-3475-01A
Merck Sharp & Dohme LLC
Phase 1/2
Recruiting
450 enrolled
NCT07286149
2026-03-16
MK-3475-01F
Merck Sharp & Dohme LLC
Phase 1/2
Recruiting
190 enrolled